RxDoctor Payments Data

Monique Husbands Onyeukwu, MD

Family Medicine · Ellicott City, MDNPI 1164743563

Payments from drug & device makers

$4,171in general payments, 2019–2025

Across 269 payments — averaging $15.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$822
  • AbbVie$506
  • Amgen$329
  • AstraZeneca$318
  • Pfizer$297
  • Lilly USA, LLC$294
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,171100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,171 in reported general payments places this provider in the 85th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$144,853
Medicare patients
365
Services billed
1,669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$79,474
OzempicSemaglutide35$48,108
JanuviaSitagliptin Phosphate45$46,489
XareltoRivaroxaban23$37,073
JardianceEmpagliflozin23$33,622
EntrestoSacubitril/Valsartan17$30,752
FarxigaDapagliflozin Propanediol19$24,314
TrulicityDulaglutide21$19,729
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$19,265
Rosuvastatin Calcium266$8,974
Ezetimibe150$8,030
Atorvastatin Calcium483$7,502
Dexlansoprazole DrDexlansoprazole14$6,515
VascepaIcosapent Ethyl11$4,319
Amlodipine Besylate419$3,965

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$297$79,47460 claims
Novo NordiskOzempic$822$48,10835 claims
MerckJanuvia$198$46,48945 claims
Johnson & JohnsonXarelto$13$37,07323 claims
Boehringer IngelheimJardiance$210$33,62223 claims
NovartisEntresto$19$30,75217 claims
AstraZenecaFarxiga$318$24,31419 claims
Lilly USA, LLCTrulicity$294$19,72921 claims
GSKTrelegy Ellipta$115$19,26514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Ellicott City

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →